• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激动剂结合的 TR:RXR 异二聚体中负协同作用的结构基础。

Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.

机构信息

University of Tennessee, Knoxville, TN 37996, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6084-7. doi: 10.1073/pnas.1119852109. Epub 2012 Apr 2.

DOI:10.1073/pnas.1119852109
PMID:22474364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3341017/
Abstract

Thyroid hormones such as 3,3',5 triiodo-L-thyronine (T3) control numerous aspects of mammalian development and metabolism. The actions of such hormones are mediated by specific thyroid hormone receptors (TRs). TR belongs to the nuclear receptor family of modular transcription factors that binds to specific DNA-response elements within target promoters. These receptors can function as homo- or heterodimers such as TR:9-cis retinoic acid receptor (RXR). Here, we present the atomic resolution structure of the TRα•T3:RXRα•9-cis retinoic acid (9c) ligand binding domain heterodimer complex at 2.95 Å along with T3 hormone binding and dissociation and coactivator binding studies. Our data provide a structural basis for allosteric communication between T3 and 9c and negative cooperativity between their binding pockets. In this structure, both TR and RXR are in the active state conformation for optimal binding to coactivator proteins. However, the structure of TR•T3 within TR•T3:RXR•9c is in a relative state of disorder, and the observed kinetics of binding show that T3 dissociates more rapidly from TR•T3:RXR•9c than from TR•T3:RXR. Also, coactivator binding studies with a steroid receptor coactivator-1 (receptor interaction domains 1-3) fragment show lower affinities (K(a)) for TR•T3:RXR•9c than TR•T3:RXR. Our study corroborates previously reported observations from cell-based and binding studies and offers a structural mechanism for the repression of TR•T3:RXR transactivation by RXR agonists. Furthermore, the recent discoveries of multiple endogenous RXR agonists that mediate physiological tasks such as lipid biosynthesis underscore the pharmacological importance of negative cooperativity in ligand binding within TR:RXR heterodimers.

摘要

甲状腺激素,如 3,3',5-三碘-L-甲状腺素(T3),控制着哺乳动物发育和代谢的众多方面。这些激素的作用是通过特定的甲状腺激素受体(TR)介导的。TR 属于核受体家族的模块化转录因子,它与靶启动子内的特定 DNA 反应元件结合。这些受体可以作为同源或异源二聚体发挥作用,如 TR:9-顺式视黄酸受体(RXR)。在这里,我们展示了 TRα•T3:RXRα•9-顺式视黄酸(9c)配体结合域异二聚体复合物的原子分辨率结构,分辨率为 2.95Å,同时进行了 T3 激素结合和解离以及共激活剂结合研究。我们的数据为 T3 和 9c 之间的变构通讯以及它们结合口袋之间的负协同作用提供了结构基础。在这个结构中,TR 和 RXR 都处于活性构象,以最佳方式结合共激活蛋白。然而,TR•T3 内的 TR•T3:RXR•9c 的结构处于相对无序的状态,观察到的结合动力学表明,T3 从 TR•T3:RXR•9c 中的解离速度比从 TR•T3:RXR 中的解离速度更快。此外,用甾体受体共激活因子-1(受体相互作用域 1-3)片段进行的共激活因子结合研究表明,TR•T3:RXR•9c 的亲和力(K(a))比 TR•T3:RXR 低。我们的研究证实了之前基于细胞和结合研究的观察结果,并为 RXR 激动剂对 TR•T3:RXR 转录激活的抑制提供了结构机制。此外,最近发现的多种内源性 RXR 激动剂介导脂质生物合成等生理任务,突显了配体结合中负协同作用在 TR:RXR 异二聚体中的药理学重要性。

相似文献

1
Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.激动剂结合的 TR:RXR 异二聚体中负协同作用的结构基础。
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6084-7. doi: 10.1073/pnas.1119852109. Epub 2012 Apr 2.
2
RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment.视黄酸X受体激动剂在9-顺式视黄酸处理后调节甲状腺激素受体:共抑制因子解离。
Mol Endocrinol. 2015 Feb;29(2):258-73. doi: 10.1210/me.2014-1251. Epub 2014 Dec 26.
3
Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.类固醇受体辅激活因子-1在甲状腺激素受体介导的配体诱导的反式激活中的功能作用分析。
Mol Endocrinol. 1997 Jun;11(6):755-67. doi: 10.1210/mend.11.6.0003.
4
Cross-talk between thyroid hormone and specific retinoid X receptor subtypes in yeast selectively regulates cognate ligand actions.甲状腺激素与酵母中特定视黄酸X受体亚型之间的相互作用选择性地调节同源配体的作用。
Gene Expr. 1996;6(3):169-84.
5
Direct interdomain interactions can mediate allosterism in the thyroid receptor.直接的结构域间相互作用可介导甲状腺受体中的变构效应。
J Biol Chem. 2009 Aug 21;284(34):22517-24. doi: 10.1074/jbc.M109.026682. Epub 2009 Jun 26.
6
Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.甲状腺激素受体不会与维生素D受体形成异源二聚体,但会抑制维生素D受体介导的反式激活。
Mol Endocrinol. 1998 Sep;12(9):1367-79. doi: 10.1210/mend.12.9.0165.
7
Triiodothyronine (T3) differentially affects T3-receptor/retinoic acid receptor and T3-receptor/retinoid X receptor heterodimer binding to DNA.三碘甲状腺原氨酸(T3)对T3受体/视黄酸受体以及T3受体/视黄醇X受体异二聚体与DNA的结合有不同影响。
J Biol Chem. 1992 Nov 15;267(32):23248-52.
8
Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer.维甲酸X受体(RXR)和RXR配体在动态调节甲状腺激素受体/RXR异二聚体活性中的新作用。
J Biol Chem. 2004 Feb 27;279(9):7427-37. doi: 10.1074/jbc.M311596200. Epub 2003 Dec 10.
9
Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.通过结构和荧光各向异性研究对维甲酸受体/维甲酸X受体(RAR/RXR)异源二聚体与转录共激活因子之间的相互作用进行表征。
J Biol Chem. 2005 Jan 14;280(2):1625-33. doi: 10.1074/jbc.M409302200. Epub 2004 Nov 4.
10
Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.维甲酸受体和甲状腺激素受体的异二聚体表现出独特的组合调控特性。
Mol Endocrinol. 2005 Apr;19(4):863-78. doi: 10.1210/me.2004-0210. Epub 2005 Jan 13.

引用本文的文献

1
Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential.视黄酸X受体异二聚体在肝功能中的作用:结构见解与治疗潜力
Front Pharmacol. 2024 Oct 16;15:1464655. doi: 10.3389/fphar.2024.1464655. eCollection 2024.
2
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.国际基础与临床药理学联盟第十三分会:核受体超家族-2023 更新。
Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16.
3
Cooperativity as quantification and optimization paradigm for nuclear receptor modulators.协同性作为核受体调节剂的量化与优化范式。
Chem Sci. 2022 Jan 19;13(9):2744-2752. doi: 10.1039/d1sc06426f. eCollection 2022 Mar 2.
4
Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt.RORγt 的变构配体结合位点与正位配体结合位点之间的协同作用。
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6). doi: 10.1073/pnas.2021287118.
5
Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance.揭示甲状腺激素抵抗的突变诱导受体变构机制。
iScience. 2019 Oct 25;20:489-496. doi: 10.1016/j.isci.2019.10.002. Epub 2019 Oct 2.
6
Thyroid Hormone Resistance in Identical Twin Sisters with Atrial Fibrillation: Case Report and Review of the Literature.患有心房颤动的同卵双胞胎姐妹中的甲状腺激素抵抗:病例报告及文献综述
J Endocrinol Diabetes. 2018;5(4). doi: 10.15226/2374-6890/5/4/01111. Epub 2018 Jul 23.
7
Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.核受体 FXR 和 RXR 异二聚体复合物的结构见解。
J Biol Chem. 2018 Aug 10;293(32):12535-12541. doi: 10.1074/jbc.RA118.004188. Epub 2018 Jun 22.
8
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses.AlloFinder:一种变构调节剂发现和变构体组分析的策略。
Nucleic Acids Res. 2018 Jul 2;46(W1):W451-W458. doi: 10.1093/nar/gky374.
9
Allosteric pathways in nuclear receptors - Potential targets for drug design.核受体中的变构途径——药物设计的潜在靶点。
Pharmacol Ther. 2018 Mar;183:152-159. doi: 10.1016/j.pharmthera.2017.10.014. Epub 2017 Oct 31.
10
DNA-induced unfolding of the thyroid hormone receptor α A/B domain through allostery.DNA通过变构作用诱导甲状腺激素受体α A/B结构域展开。
FEBS Open Bio. 2017 May 15;7(6):854-864. doi: 10.1002/2211-5463.12229. eCollection 2017 Jun.

本文引用的文献

1
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators.一组化学相关的孕激素受体调节剂激动剂和拮抗剂的作用机制研究
J Biol Chem. 2011 Oct 7;286(40):35079-86. doi: 10.1074/jbc.M111.273029. Epub 2011 Aug 17.
2
Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex.直接检测多构象受体-配体复合物中结构分辨的动力学。
J Am Chem Soc. 2011 Apr 27;133(16):6422-8. doi: 10.1021/ja2005253. Epub 2011 Apr 6.
3
Helix 11 dynamics is critical for constitutive androstane receptor activity.螺旋 11 动力学对组成型雄烷受体活性至关重要。
Structure. 2011 Jan 12;19(1):37-44. doi: 10.1016/j.str.2010.11.008.
4
Translational potential of thyroid hormone and its analogs.甲状腺激素及其类似物的转化潜力。
J Mol Cell Cardiol. 2011 Oct;51(4):506-11. doi: 10.1016/j.yjmcc.2010.12.012. Epub 2011 Jan 5.
5
NR4A orphan nuclear receptors influence retinoic acid and docosahexaenoic acid signaling via up-regulation of fatty acid binding protein 5.NR4A 孤儿核受体通过上调脂肪酸结合蛋白 5 影响视黄酸和二十二碳六烯酸信号转导。
Biochem Biophys Res Commun. 2009 Dec 25;390(4):1186-91. doi: 10.1016/j.bbrc.2009.10.116. Epub 2009 Oct 25.
6
Direct interdomain interactions can mediate allosterism in the thyroid receptor.直接的结构域间相互作用可介导甲状腺受体中的变构效应。
J Biol Chem. 2009 Aug 21;284(34):22517-24. doi: 10.1074/jbc.M109.026682. Epub 2009 Jun 26.
7
Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.配体调节的核受体共抑制因子和共激活因子结合的定量分析,这是决定甲状腺激素受体配体效力和功效的关键相互作用。
Biochemistry. 2008 Jul 15;47(28):7465-76. doi: 10.1021/bi800393u. Epub 2008 Jun 18.
8
Coactivator recruitment is enhanced by thyroid hormone receptor trimers.甲状腺激素受体三聚体可增强辅激活因子的募集。
Mol Cell Endocrinol. 2008 Jan 2;280(1-2):47-62. doi: 10.1016/j.mce.2007.09.011. Epub 2007 Oct 6.
9
Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination.甲状腺激素敏感性降低综合征:激素受体、细胞转运体和脱碘作用的基因缺陷。
Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):277-305. doi: 10.1016/j.beem.2007.03.005.
10
Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.甲状腺激素受体铰链区的结构重排及其在受体功能中的假定作用。
J Mol Biol. 2006 Jul 14;360(3):586-98. doi: 10.1016/j.jmb.2006.05.008. Epub 2006 May 19.